Advertisement
YOU ARE HERE: LAT HomeCollectionsRobert E Martini
IN THE NEWS

Robert E Martini

MORE STORIES ABOUT:
FEATURED ARTICLES
BUSINESS
January 11, 1993 | James M. Gomez, Times staff writer
Flush from a spate of acquisitions that included an Alabama competitor last year, Robert E. Martini is contemplating where his company will go from here. Martini clearly wants to make his firm, Orange-based Bergen Brunswig Corp., the largest drug wholesaler in the nation. Martini is also concerned about talk of controlling pharmaceutical prices, the FDA and the effect of government-mandated managed-care proposals on his company and his clients.
ARTICLES BY DATE
BUSINESS
August 25, 1998 | BARBARA MARSH, TIMES STAFF WRITER
Bergen Brunswig Corp. paid Chairman Robert E. Martini $3.2 million in the year he stepped down as chief executive of the Orange-based drug wholesaler. Martini, the company's biggest shareholder, received nearly $2.3 million in retirement-related benefits, according to a proxy filing Monday for the company's fiscal year ended Sept. 30, 1997. The former executive, who is 66, succeeded his older brother, the late Emil Martini, as chief executive in 1990 and as chairman in 1992.
Advertisement
BUSINESS
August 25, 1998 | BARBARA MARSH, TIMES STAFF WRITER
Bergen Brunswig Corp. paid Chairman Robert E. Martini $3.2 million in the year he stepped down as chief executive of the Orange-based drug wholesaler. Martini, the company's biggest shareholder, received nearly $2.3 million in retirement-related benefits, according to a proxy filing Monday for the company's fiscal year ended Sept. 30, 1997. The former executive, who is 66, succeeded his older brother, the late Emil Martini, as chief executive in 1990 and as chairman in 1992.
BUSINESS
January 11, 1993 | James M. Gomez, Times staff writer
Flush from a spate of acquisitions that included an Alabama competitor last year, Robert E. Martini is contemplating where his company will go from here. Martini clearly wants to make his firm, Orange-based Bergen Brunswig Corp., the largest drug wholesaler in the nation. Martini is also concerned about talk of controlling pharmaceutical prices, the FDA and the effect of government-mandated managed-care proposals on his company and his clients.
BUSINESS
May 17, 1992 | TED JOHNSON, SPECIAL TO THE TIMES
For many Orange County executives, 1991 was a year when their pay packages came under greater shareholder scrutiny and corporate boards were cautious in handing out cash bonuses and perks. It mirrored a trend statewide of keeping executive compensation in line with a company's financial performance. Of the top 100 county executives on the list of publicly traded companies, one-third of the officers saw their cash compensation remain unchanged or had it reduced.
BUSINESS
September 9, 1995
Bergen Brunswig's president and chief operating officer Dwight Steffensen has resigned, the pharmaceuticals supplier said Friday. Steffensen's resignation will become effective in mid-October, but he will remain on the board. The company said Steffensen, who joined the company in 1985 and became president in 1992, is leaving to pursue other opportunities. Robert E. Martini, chairman and chief executive, will assume Steffensen's duties next month until a successor is named.
BUSINESS
October 4, 2000 | Dow Jones
Bergen Brunswig Corp., the nation's third-largest distributor of pharmaceuticals and medical supplies, said Tuesday that James R. Mellor was named chairman of the board's executive committee. The company, based in Orange, said in a press release that the executive committee exercises corporate oversight when the board is not in session. Mellor, a director since 1979, replaces Robert E. Martini as head of the executive committee.
BUSINESS
November 1, 1996
Bergen Brunswig Corp. posted record earnings and revenue for the fiscal year ended Sept. 30, the distributor of pharmaceuticals and medical surgical supplies said Thursday. Net income rose 15.6% to $73.9 million, or $1.83 per share, from $63.9 million, or $1.61 per share, for the previous year. Revenue climbed nearly 18%, outpacing the company's top two competitors, said Robert E. Martini, chairman and chief executive. Revenue totaled $9.9 billion, up from $8.4 billion.
BUSINESS
January 18, 1992
Bergen Brunswig Corp. announced Friday that its drug distribution subsidiary has agreed to acquire the pharmaceutical distribution assets of Owens & Minor Inc. for about $50 million in cash. The acquisition, expected to close in late February after regulatory and other approvals, will allow Bergen Brunswig Drug Co. to extend its distribution network from Virginia into the mid-Atlantic states and to quadruple its annual sales from $100 million to $400 million, said Robert E.
BUSINESS
February 25, 1992 | GREGORY CROUCH, TIMES STAFF WRITER
Bergen Brunswig Corp. said Monday that it has sold its Commtron subsidiary, the nation's largest distributor of movie videos, for $78 million to a Nashville-based company. Bergen is selling its 80% stake in Des Moines-based Commtron Corp. to focus solely on its drug distribution business, which accounts for 90% of the Orange company's sales and most of its profits. Ingram Entertainment, a unit of Nashville-based Ingram Industries, has agreed to pay Bergen and other Commtron shareholders $7.
BUSINESS
December 22, 1999
Brent R. Martini, president of Bergen Brunswig Corp.'s largest subsidiary, has been named to an expanded board of directors. Martini, who joined Bergen in 1987, is president of Bergen Brunswig Drug Co. and the son of Robert E. Martini, chairman and chief executive officer of the parent company in Orange. Bergen said it has expanded the board to 12 members with the addition of Martini. * Scott Simon has joined the Pacific Investment Management Co.
Los Angeles Times Articles
|